Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia." Kidney International 2025;107:169-179.
Publication
, Journal Article
Charytan, DM; Winkelmayer, WC; Granger, CB; Middleton, JP; Herzog, CA; Chertow, GM; Eudicone, JM; Whitson, JD; Tumlin, JA; ADAPT Investigators
Published in: Kidney Int
June 2025
Duke Scholars
Published In
Kidney Int
DOI
EISSN
1523-1755
Publication Date
June 2025
Volume
107
Issue
6
Start / End Page
1123
Location
United States
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Charytan, D. M., Winkelmayer, W. C., Granger, C. B., Middleton, J. P., Herzog, C. A., Chertow, G. M., … ADAPT Investigators. (2025). Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia." Kidney International 2025;107:169-179. Kidney Int, 107(6), 1123. https://doi.org/10.1016/j.kint.2025.03.009
Charytan, David M., Wolfgang C. Winkelmayer, Christopher B. Granger, John P. Middleton, Charles A. Herzog, Glenn M. Chertow, James M. Eudicone, Jeremy D. Whitson, James A. Tumlin, and ADAPT Investigators. “Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia." Kidney International 2025;107:169-179.” Kidney Int 107, no. 6 (June 2025): 1123. https://doi.org/10.1016/j.kint.2025.03.009.
Charytan DM, Winkelmayer WC, Granger CB, Middleton JP, Herzog CA, Chertow GM, et al. Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia." Kidney International 2025;107:169-179. Kidney Int. 2025 Jun;107(6):1123.
Charytan, David M., et al. “Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia." Kidney International 2025;107:169-179.” Kidney Int, vol. 107, no. 6, June 2025, p. 1123. Pubmed, doi:10.1016/j.kint.2025.03.009.
Charytan DM, Winkelmayer WC, Granger CB, Middleton JP, Herzog CA, Chertow GM, Eudicone JM, Whitson JD, Tumlin JA, ADAPT Investigators. Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia." Kidney International 2025;107:169-179. Kidney Int. 2025 Jun;107(6):1123.
Published In
Kidney Int
DOI
EISSN
1523-1755
Publication Date
June 2025
Volume
107
Issue
6
Start / End Page
1123
Location
United States
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences